advertisement

diseases & conditions

rare diseases: 'it's difficult to get the government to understand the importance of adopting new drugs'

john clark, who lives with polycythemia vera, a myeloproliferative neoplasm (mpn), says one of the biggest challenges for people with an mpn is access to medication. his treatment costs $60k per year.
vanessa hrvatin
feb 18 2022

scientists identify genes responsible for coronary heart disease

the findings also offers hope for people living with other vascular diseases, like migraine.
chris arnold
feb 18 2022

u.s. leukemia patient first woman to be cured of hiv with stem cell transplant

scientists are optimistic, while dr. anthony fauci cautions people with hiv not to "get their hopes up."
chris arnold
feb 17 2022

rare diseases: 'advocacy is a collective effort. you are never fighting alone'

catherine boivin, who lives with spinal muscular atrophy, wants all people living with the progressive muscle-weakening disease to have access to treatments and the best standard of care.
vanessa hrvatin
feb 16 2022

scientists discover how caffeine protects against cardiovascular disease

researchers say that just two to three average-sized cups of coffee per day contains enough caffeine to trigger a cascade effect.
brighter world, mcmaster university
feb 16 2022

'the way we're curing our patients is through poisoning them'

treatments for cancer in kids, while mostly effective, also cause serious side effects, something one of canada's leading pediatric oncologists hopes investment in research will change.
karen hawthorne
feb 15 2022

researchers find new targets for cystic fibrosis therapy

cystic fibrosis causes lung damage and a loss of lung function which eventually leads to death in the majority of patients.
dave yasvinski
feb 15 2022

exercising after vaccination pumps up antibodies: study

the research is the first to demonstrate a link between physical activity and the body’s antibody response to the pfizer-biontech covid-19 vaccine.
dave yasvinski
feb 14 2022
powered by
canadian centre for caregiving excellence
powered by
migraine canada
powered by
diabetes canada

rare diseases: 'it's difficult to get the government to understand the importance of adopting new drugs'

john clark, who lives with polycythemia vera, a myeloproliferative neoplasm (mpn), says one of the biggest challenges for people with an mpn is access to medication. his treatment costs $60k per year.
vanessa hrvatin
feb 18 2022

scientists identify genes responsible for coronary heart disease

the findings also offers hope for people living with other vascular diseases, like migraine.
chris arnold
feb 18 2022

u.s. leukemia patient first woman to be cured of hiv with stem cell transplant

scientists are optimistic, while dr. anthony fauci cautions people with hiv not to "get their hopes up."
chris arnold
feb 17 2022

rare diseases: 'advocacy is a collective effort. you are never fighting alone'

catherine boivin, who lives with spinal muscular atrophy, wants all people living with the progressive muscle-weakening disease to have access to treatments and the best standard of care.
vanessa hrvatin
feb 16 2022
powered by
canadian centre for caregiving excellence

scientists discover how caffeine protects against cardiovascular disease

researchers say that just two to three average-sized cups of coffee per day contains enough caffeine to trigger a cascade effect.
brighter world, mcmaster university
feb 16 2022

'the way we're curing our patients is through poisoning them'

treatments for cancer in kids, while mostly effective, also cause serious side effects, something one of canada's leading pediatric oncologists hopes investment in research will change.
karen hawthorne
feb 15 2022

researchers find new targets for cystic fibrosis therapy

cystic fibrosis causes lung damage and a loss of lung function which eventually leads to death in the majority of patients.
dave yasvinski
feb 15 2022

exercising after vaccination pumps up antibodies: study

the research is the first to demonstrate a link between physical activity and the body’s antibody response to the pfizer-biontech covid-19 vaccine.
dave yasvinski
feb 14 2022
powered by
migraine canada

advertisement

advertisement